Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

Gene Editing and Its Applications in Biomedicine

Development and application of CRISPR/Cas9 technologies in genomic editing.

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Development of Genome Editing and Gene Regulation Using CRISPR System

Genome-Editing Technologies: Principles and Applications.

Principles and applications of genome-editing technologies in cancer research

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Evolution and application of gene editing technology

The application and development of CRISPR Cas9

[Gene Editing Technology and Its Recent Progress in Disease Therapy].

Gene editing: from technologies to applications in research and beyond

Applications of CRISPR technologies to the development of gene and cell therapy

Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.

CRISPR-Cas9 Gene Editing: Current Progress and Future Applications

Recent Progress in CRISPR/Cas9 Technology

Basic Principles and Clinical Applications of CRISPR-Based Genome Editing